Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 5 of 3067 results
Sort by: relevance publication year
Showing results for ISSN matching 1759-4774

MRI, TRUS or both?

JOURNAL ARTICLE published May 2020 in Nature Reviews Clinical Oncology

Authors: Peter Sidaway

https://doi.org/10.1038/s41571-020-0358-2 Actions

Benefits of adding ADT to RT confirmed

JOURNAL ARTICLE published January 2020 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-019-0298-x Actions

KTE-X19 active in MCL

JOURNAL ARTICLE published June 2020 in Nature Reviews Clinical Oncology

Authors: Diana Romero

https://doi.org/10.1038/s41571-020-0373-3 Actions

Two steps forward and one step back

JOURNAL ARTICLE published February 2019 in Nature Reviews Clinical Oncology

Authors: Florian Lordick | Elizabeth C. Smyth

https://doi.org/10.1038/s41571-018-0154-4 Actions

Healthier bones and less recurrence with denosumab

JOURNAL ARTICLE published May 2019 in Nature Reviews Clinical Oncology

Authors: Diana Romero

https://doi.org/10.1038/s41571-019-0197-1 Actions

What’s new under the Sun for ICIs?

JOURNAL ARTICLE published October 2018 in Nature Reviews Clinical Oncology

Authors: Diana Romero

https://doi.org/10.1038/s41571-018-0094-z Actions

Sequencing cells of the immune TME

JOURNAL ARTICLE published September 2018 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-018-0069-0 Actions

A new standard for EGFR-mutant NSCLC?

JOURNAL ARTICLE published October 2019 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-019-0271-8 Actions

PERSEPHONE — implications for clinical practice in 2019

JOURNAL ARTICLE published November 2019 in Nature Reviews Clinical Oncology

Authors: Noam Pondé | Evandro de Azambuja

https://doi.org/10.1038/s41571-019-0256-7 Actions

Neoadjuvant pembrolizumab shows promise

JOURNAL ARTICLE published January 2019 in Nature Reviews Clinical Oncology

Authors: Peter Sidaway

https://doi.org/10.1038/s41571-018-0131-y Actions

Microenvironment plasticity confers cetuximab resistance

JOURNAL ARTICLE published September 2019 in Nature Reviews Clinical Oncology

Authors: Peter Sidaway

https://doi.org/10.1038/s41571-019-0259-4 Actions

CD19 affinity — is lower also better?

JOURNAL ARTICLE published November 2019 in Nature Reviews Clinical Oncology

Authors: Peter Sidaway

https://doi.org/10.1038/s41571-019-0278-1 Actions

From the 2019 ASCO Annual Meeting

JOURNAL ARTICLE published August 2019 in Nature Reviews Clinical Oncology

Authors: Diana Romero

https://doi.org/10.1038/s41571-019-0245-x Actions

BRAF+MEKi and ICI triplets show promise in melanoma

JOURNAL ARTICLE published September 2019 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-019-0247-8 Actions

BEACON of hope in BRAFV600E CRC

JOURNAL ARTICLE published December 2019 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-019-0286-1 Actions

Perioperative FLOT superior to ECF/X

JOURNAL ARTICLE published August 2019 in Nature Reviews Clinical Oncology

Authors: Conor A. Bradley

https://doi.org/10.1038/s41571-019-0215-3 Actions

Cytoreductive nephrectomy in metastatic renal cancer — less is more

JOURNAL ARTICLE published October 2018 in Nature Reviews Clinical Oncology

Authors: Axel Bex | John Haanen

https://doi.org/10.1038/s41571-018-0065-4 Actions

ctDNA predicts outcomes in DLBCL

JOURNAL ARTICLE published November 2018 in Nature Reviews Clinical Oncology

Authors: Peter Sidaway

https://doi.org/10.1038/s41571-018-0091-2 Actions

ECHELON-2 — brentuximab raises PTCL outcomes to new levels

JOURNAL ARTICLE published March 2019 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-018-0163-3 Actions

Pembrolizumab can delay progression of TNBC

JOURNAL ARTICLE published February 2021 in Nature Reviews Clinical Oncology

Authors: David Killock

https://doi.org/10.1038/s41571-020-00465-x Actions
Feedback: support@crossref.org